Skip to content

SKILL.md

Latest commit

 

History

History
216 lines (159 loc) · 7.12 KB

SKILL.md

File metadata and controls

216 lines (159 loc) · 7.12 KB

name: 'cryoem-ai-drug-design-agent' description: 'AI-powered integration of cryo-EM structural data with generative AI and molecular dynamics for structure-based drug design targeting flexible proteins and membrane complexes.' measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes. allowed-tools:

  • read_file
  • run_shell_command

Cryo-EM AI Drug Design Agent

The Cryo-EM AI Drug Design Agent integrates cryo-electron microscopy structural data with AlphaFold3, generative AI, and molecular dynamics for structure-based drug design. It enables targeting of previously "undruggable" proteins including flexible, membrane-bound, and large macromolecular complexes through high-resolution structure-guided optimization.

When to Use This Skill

  • When designing drugs against cryo-EM-solved targets.
  • For fragment-based drug discovery with EM structures.
  • To model ligand binding in flexible protein regions.
  • When targeting membrane proteins and large complexes.
  • For integrating AlphaFold predictions with experimental EM density.

Core Capabilities

  1. Density-Guided Design: Fit ligands into cryo-EM density maps.

  2. AlphaFold Integration: Combine AF3 predictions with EM data.

  3. Flexible Docking: Account for protein dynamics in binding.

  4. Fragment Screening: Virtual fragment screening with EM structures.

  5. Complex Targeting: Design for multi-protein assemblies.

  6. Dynamics-Based Design: Incorporate conformational flexibility.

Cryo-EM for Drug Discovery

Target Class Cryo-EM Advantage Drug Discovery Application
GPCRs Native lipid environment Allosteric sites
Ion Channels Multiple conformations State-specific design
Transporters Conformational states Mechanism-based
Ribosomes Antibiotic binding New antibiotics
Viral Proteins Large assemblies Vaccines, antivirals
Intrinsically Disordered Flexible regions Challenging targets

Workflow

  1. Input: Cryo-EM density map, protein sequence, ligand/fragment.

  2. Structure Refinement: AlphaFold + density-guided refinement.

  3. Binding Site Identification: Detect pockets in EM structure.

  4. Ligand Placement: Density-guided ligand fitting.

  5. MD Simulation: Flexible binding simulation.

  6. Optimization: Generative design around hits.

  7. Output: Optimized ligands, binding models, design recommendations.

Example Usage

User: "Design ligands for this GPCR cryo-EM structure, accounting for receptor flexibility in the binding pocket."

Agent Action:

python3 Skills/Structural_Biology/CryoEM_AI_Drug_Design_Agent/design_from_cryoem.py \
    --density_map gpcr_3.2A.mrc \
    --protein_sequence gpcr.fasta \
    --alphafold_model gpcr_af2.pdb \
    --resolution 3.2 \
    --ligand_screening fragment_library.sdf \
    --binding_site_residues "3.32,5.46,6.48,7.39" \
    --md_refinement true \
    --generative_optimization true \
    --output gpcr_drug_design/

Input Requirements

Input Format Purpose
Density Map MRC/MAP EM density
Protein Sequence FASTA AlphaFold input
Resolution Float (Å) Quality metric
Ligand Library SDF Virtual screening
Known Ligand Optional SDF Starting point

Output Components

Output Description Format
Refined Structure EM + AF combined .pdb
Ligand Poses Density-fitted poses .sdf
Binding Scores Affinity predictions .csv
Optimized Compounds Generative designs .sdf
MD Trajectory Flexibility analysis .xtc
Design Report Recommendations .pdf

AI/ML Components

Structure Prediction:

  • AlphaFold3 for initial model
  • Density-guided refinement
  • Confidence scoring (pLDDT, local resolution)

Ligand Design:

  • Generative AI (diffusion, VAE)
  • Reinforcement learning optimization
  • Multi-objective scoring

Dynamics Integration:

  • Molecular dynamics simulation
  • Ensemble docking
  • Flexibility-aware scoring

Resolution Considerations

Resolution Applications Limitations
<3.0 Å Fragment screening, detailed design Rare
3.0-4.0 Å Drug optimization, binding mode Most targets
4.0-5.0 Å Pocket identification, scaffold Less detail
>5.0 Å Architecture, general binding Low for SBDD

AlphaFold3 + Cryo-EM Integration

Scenario Approach Benefit
Missing Loops AF3 prediction Complete structure
Flexible Regions Ensemble models Multiple conformations
Low Resolution AF3 template Higher confidence
Ligand Binding AF3 complex prediction Binding mode

Prerequisites

  • Python 3.10+
  • AlphaFold3, ChimeraX
  • GROMACS/OpenMM for MD
  • RDKit, AutoDock Vina
  • GPU with 16GB+ VRAM

Related Skills

  • Time_Resolved_CryoEM_Agent - Dynamics from EM
  • PROTAC_Design_Agent - Degrader design
  • Molecular_Glue_Discovery_Agent - Glue design
  • AlphaFold3_Agent - Structure prediction

Fragment-Based Discovery with Cryo-EM

Step Method Cryo-EM Role
Fragment Screening Virtual dock to EM Density-guided
Hit Identification Cryo-EM soaking Experimental validation
Fragment Growing EM + modeling Structure guidance
Lead Optimization Iterative EM Binding mode confirmation

Membrane Protein Targets

Target Type Cryo-EM Advantage Examples
GPCRs Native membrane Numerous drugs
Ion Channels State-dependent Painkillers, antiepileptics
Transporters Mechanism insight Cancer, infection
Receptors Complex structures Immunotherapy

Special Considerations

  1. Resolution Limits: Design confidence depends on resolution
  2. Map Quality: Local resolution varies across structure
  3. Conformational States: Multiple states may be captured
  4. Ligand Density: May be weak at lower resolution
  5. Validation: Experimental validation essential

Quality Metrics

Metric Purpose Threshold
Global Resolution Overall quality <4.0 Å for SBDD
Local Resolution Binding site quality <3.5 Å preferred
Map Correlation Model-to-map fit >0.8
Real-Space R Atomic fit <0.3
Ligand CCC Ligand fit >0.6

Drug Discovery Success Stories

Drug Target Cryo-EM Role
Numerous GPCRs Structure determination
Antibiotics Ribosome Binding mode
Antivirals Spike protein Epitope mapping
Various Ion channels State-specific design

Author

AI Group - Biomedical AI Platform